Ravi Walli

892 total citations
9 papers, 671 citations indexed

About

Ravi Walli is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Ravi Walli has authored 9 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Virology and 6 papers in Emergency Medicine. Recurrent topics in Ravi Walli's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and HIV-related health complications and treatments (6 papers). Ravi Walli is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and HIV-related health complications and treatments (6 papers). Ravi Walli collaborates with scholars based in Germany. Ravi Walli's co-authors include Johannes R. Bogner, Gerlinde M. Michl, Frank D. Goebel, Thomas Demant, Hans Jäger, R Landgraf, C. Dieterle, F. D. Goebel, Stephan Segerer and Dieter Mühlbayer and has published in prestigious journals such as AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes and Infection.

In The Last Decade

Ravi Walli

8 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ravi Walli Germany	7	571	488	407	63	55	9	671
Gerlinde M. Michl Germany	7	643 1.1×	545 1.1×	448 1.1×	70 1.1×	54 1.0×	9	737
Daria Pocaterra Italy	12	335 0.6×	257 0.5×	151 0.4×	66 1.0×	96 1.7×	21	438
Consuelo Viladés Spain	17	257 0.5×	255 0.5×	335 0.8×	29 0.5×	18 0.3×	39	563
Barbara A. da Silva United States	10	455 0.8×	500 1.0×	427 1.0×	19 0.3×	17 0.3×	11	794
S Staszewski Germany	8	221 0.4×	393 0.8×	268 0.7×	15 0.2×	35 0.6×	25	494
Marit G. A. van Vonderen Netherlands	8	200 0.4×	100 0.2×	114 0.3×	41 0.7×	37 0.7×	12	322
Michael Basar United States	6	204 0.4×	211 0.4×	149 0.4×	23 0.4×	14 0.3×	8	334
Victoria Wirtz United States	11	359 0.6×	820 1.7×	591 1.5×	11 0.2×	17 0.3×	21	904
Stefania Salpietro Italy	12	141 0.2×	274 0.6×	201 0.5×	29 0.5×	23 0.4×	41	422
Michael Giordano United States	6	292 0.5×	502 1.0×	389 1.0×	20 0.3×	25 0.5×	10	582

Countries citing papers authored by Ravi Walli

Since Specialization

Citations

This map shows the geographic impact of Ravi Walli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Walli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Walli more than expected).

Fields of papers citing papers by Ravi Walli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Walli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Walli. The network helps show where Ravi Walli may publish in the future.

Co-authorship network of co-authors of Ravi Walli

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Walli. A scholar is included among the top collaborators of Ravi Walli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Walli. Ravi Walli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Walli, Ravi, et al.. (2008). Metabolische Komplikationen der antiretroviralen Therapie der HIV-Infektion. DMW - Deutsche Medizinische Wochenschrift. 125(24). 771–773.

2.

Kurowski, Michael, et al.. (2007). Fosamprenavir/ritonavir plus tenofovir does not affect amprenavir pharmacokinetics: no effect of tenofovir. AIDS. 21(10). 1368–1370. 9 indexed citations

3.

Michl, Gerlinde M., Ravi Walli, Johannes R. Bogner, et al.. (2001). Alterations of Apolipoprotein B Metabolism in HIV-Infected Patients With Antiretroviral Combination Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(3). 225–235. 49 indexed citations

4.

Bogner, Johannes R., Ravi Walli, & F. D. Goebel. (2001). Th1/Th2 Shift in HIV Lymph Nodes: No Contribution of CD60 Cells. Infection. 29(1). 32–36. 3 indexed citations

5.

Michl, Gerlinde M., Ravi Walli, Johannes R. Bogner, et al.. (2001). Alterations of Apolipoprotein B Metabolism in HIV-Infected Patients With Antiretroviral Combination Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(3). 225–235. 30 indexed citations

6.

Walli, Ravi, et al.. (1999). Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus. Research in Experimental Medicine. 199(5). 253–262. 55 indexed citations

7.

Segerer, Stephan, et al.. (1999). Hyperlipidemia under treatment with proteinase inhibitors. Infection. 27(2). 77–81. 67 indexed citations

8.

Walli, Ravi, Gerlinde M. Michl, Thomas Demant, et al.. (1998). Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS. 12(15). F167–F173. 431 indexed citations

9.

Walli, Ravi, Bruno Luckow, Antje Malo, et al.. (1998). HIV-1-Infected Long-Term Slow Progressors Heterozygous for Δ32-CCR5 Show Significantly Lower Plasma Viral Load Than Wild-Type Slow Progressors. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 18(3). 229–233. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact